<unk>  is an antineoplastic agent that is FDA approved for the treatment of relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.   Common adverse reactions include hypotension, tachycardia, abdominal pain,diarrhea, anemia, lymphocytopenia, thrombocytopenia, headache, anxiety, epistaxis,
fatigue.
Clofarabine
Vidarabine
Fludarabine 
Nelarabine
Cytarabine
Floxuridine
Cladribine
Mafosfamide